Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Diffusion Pharmaceuticals LLC is a drug discovery and development company that owns a platform technology of patented small molecule therapeutics that enhance the diffusion of oxygen to hypoxic (oxygen-starved) tissues. By applying a revolutionary approach to increase oxygen diffusion into tissue cells, Diffusion’s lead molecule trans sodium crocetinate (TSC) and other proprietary pipeline molecules could be used to treat life-threatening conditions, such as trauma, stroke, cardiovascular, respiratory, and other conditions characterized by oxygen deprivation at the cellular level. The company’s pipeline drugs, known as trans bipolar carotenoid or TBC molecules, are currently in the preclinical stage. Clinical trials are planned to support the use of TSC in ischemic ( www.diffusionpharma.com )
Diffusion Pharmaceuticals LLC
2020 Avon Court #4
Charlottesville, Virginia 22902
USA
Tel: (434) 220-0718
Fax: (434) 220-0722